Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
'Emphasise personal benefits of COVID-19 vaccine'
Thurs May 13th - Emphasising the personal benefits of the COVID-19 vaccine is the best way to persuade those who resist the injection, according to a new study. More
Mixing COVID-19 vaccine increases reactions
Thurs May 13th - Mixing COVID-19 vaccines increases an individual’s reactogenicity compared to standard schedules, according to preliminary data from the Com-COV study. More
Ovarian cancer screening does not reduce deaths
Thurs May 13th - Screening annually for ovarian cancer failed to reduce the number of deaths from the disease, UK study results show today. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
For books, child safety and gift ideas click here

Jumping genes linked to development disorders

Monday October 14th, 2019

Jumping genes are behind the genetic changes in some patients with undiagnosed neurodevelopmental diseases, according to a new study.

The largest study of its kind into childhood developmental disorders from the Wellcome Sanger Institute, Cambridge, UK, and partners in the NHS Regional Genetics services has resulted in genetic diagnoses for three children with previously undiagnosed rare developmental diseases.

The researchers believe the diagnoses for the youngsters, all of whom were enrolled in the Deciphering Developmental Disorders (DDD) project, will help the families access support and understand the disease risks for any future children.

In this study, the researchers studied the genomes of nearly 10,000 children enrolled in the project, was launched in 2010 to provide genetic diagnoses for the families of children with severe undiagnosed developmental disorders, looking for jumping genes that were not present in the parents.

Their findings are published in Nature Communications.

Transposons, known as jumping genes, are pieces of DNA that can jump around in the genome. Sometimes they land in the middle of genes and stop them working, but it not been known how often transposons lead to rare developmental disorders.

The research team found that the transposons were likely to be the cause of the developmental disorder in three previously undiagnosed patients because they had jumped into different genes in each patient, preventing them functioning properly. The study also showed a transposon in a fourth patient who had been diagnosed previously.

First author Dr Eugene Gardner, of the Wellcome Sanger Institute, said: “This is the first time we have been able to estimate the contribution of jumping genes, known as transposons, in a large sequencing cohort of rare developmental disorders.

“We found that transposons were the likely cause of the symptoms of four of the 9,738 patients, three of whom had not had previous diagnoses. These are significant diagnoses for the families involved, and this study is another step along the path to understanding the causes of developmental disorders.”

The team developed and validated analytical pathway that could quickly assess patient genomes at scale, looking for transposon-created variants. This software is now openly available for academic use and could be used to help diagnose rare transposon events in future patients.

Eugene Gardner et al. Contribution of retrotransposition to developmental disorders. Nature Communications 11 October 2019; doi: 10.1038/s41467-019-12520-y.

Tags: Child Health | Genetics | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)